High-profile cancer research

Cancer is a research network for scientists and health care professionals at Linköping University and at the County Council of Östergötland (Region Östergötland).

The network includes independent researchers and their groups whose research is related to cancer diagnosis, pathogenesis and treatment.

Unique to Cancer is its engagement of scientists from a wide range of disciplines from clinical application to engineering. By supporting interdisciplinary research, we build on strongholds of Linköping University and Regional Health Care to form a high-profile cancer research environment with the ultimate aim to improve patient care and survival.

Our aim is to create a high-profile cancer research environment at Linköping University (LiU) and the County Council of Östergötland (RÖ) with an increasing number of high-quality publications and external grants-of-excellence.

We will achieve this aim by:

  • creating a joint cancer research community at LiU and LiÖ
  • strengthening interdisciplinary connections in cancer research
  • catalyzing collaborative projects in cancer research and care
  • building on existing strong research environments and strengthen collaborations between these

Linköping Cancer Center

Linköping University is together with Region Östergötland in the process of accredit our cancer care and research by the standards of Organisation of European Cancer Institutes (OECI). OECI is a non-profit, non-governmental organisation that was established in 1979.

The aim of OECI is to promote collaborations between European healthcare providers and research institutes in the field of cancer. Our application is submitted and presently reviewed by OECI and a site visit will take place in Linköping during February 14th-15th 2024. We will keep you updated.


Closeup of small pieces of liver in a petri dish.

A liver biopsy may predict spread of pancreatic cancer

Microscopic changes in the liver can be used to predict spread of pancreatic cancer. The discovery may provide new ways of predicting the course of the disease and preventing pancreatic cancer from spreading to other organs.

Iontronic pump in thin blood vessels.

More effective cancer treatment with iontronic pump

When low doses of cancer drugs are administered continuously near malignant brain tumours using so-called iontronic technology, cancer cell growth drastically decreases. This is demonstrated in experiments with bird embryos.

Hand with IV on bed.

Cancer survivors are at increased risk of disease throughout life

A study, led by researchers at LiU and Region Östergötland, shows that cancer survivors are at greater risk for cardiovascular diseases, other cancers and other diagnoses later in life.

Other strength areas at LiU